Director Sanjay Bansal sells 32,813 equity shares on market; holding falls to 0.51%
Medicamen Biotech has disclosed an insider trading update.
- Shares Sold
- 32,813 equity shares
- Sale Value
- Rs. 1,05,42,440
- Holding Before Sale
- 1,02,813 shares (0.76%)
- Holding After Sale
- 70,000 shares (0.51%)
- Transaction Date
- 28.09.2026
What was shared
Medicamen Biotech Limited submitted a Form C continual disclosure under Regulation 7(2)(b) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, following intimation received from Mr. Sanjay Bansal, Director of the company.
The transaction
- Shares sold: 32,813 equity shares
- Value of sale: Rs. 1,05,42,440
- Transaction type: Sale, on market
- Date of sale: 28.09.2026; intimation to company on 30.09.2026
Holding before and after
- Before the sale: 1,02,813 equity shares, being 0.76% of shareholding
- After the sale: 70,000 equity shares, being 0.51% of shareholding
Derivatives
The derivatives section of the form was marked NA, meaning no futures or options transactions were reported alongside this sale.
How to read this
This is a routine post-trade disclosure that insiders must make when they buy or sell shares of their own company. It tells investors that a director has reduced his personal stake in the company. The quantity involved is small relative to total equity, moving his holding down by about a quarter of a percentage point of shareholding. Such disclosures state what was transacted but not the reason behind it, and the sale was executed on market.
More numbers
- Equity shares sold32,813 Equity Shares
- Value of sale1,05,42,440
- Shares held before sale1,02,813 Equity Shares
- Shareholding before sale0.76%
- Shares held after sale70,000
- Shareholding after sale(0.51)
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.